P
Paulo Henrique Ribeiro Fernandes Almeida
Researcher at Universidade Federal de Minas Gerais
Publications - 23
Citations - 224
Paulo Henrique Ribeiro Fernandes Almeida is an academic researcher from Universidade Federal de Minas Gerais. The author has contributed to research in topics: Insulin glargine & Type 1 diabetes. The author has an hindex of 7, co-authored 21 publications receiving 131 citations.
Papers
More filters
Journal ArticleDOI
Quality of Life of Patients with Type 1 Diabetes Mellitus Using Insulin Analog Glargine Compared with NPH Insulin: A Systematic Review and Policy Implications
Paulo Henrique Ribeiro Fernandes Almeida,Thales B. C. Silva,Francisco de Assis Acurcio,Augusto Afonso Guerra Junior,V.E. Araujo,Leonardo Maurício Diniz,Brian Godman,Alessandra Maciel Almeida,Juliana Álvares +8 more
TL;DR: The current price differential between GLA and NPH insulin in Brazil cannot be justified by these findings, and the systematic review did not consistently show any significant difference overall in QoL scores, with the use of GLA versus neutral protamine Hagedorn (NPH) insulin.
Journal ArticleDOI
Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
Wânia Cristina da Silva,Vânia Eloisa de Araújo,Vânia Eloisa de Araújo,Ellias Magalhaes Abreu Lima,Jéssica Barreto Ribeiro dos Santos,Michael Ruberson Ribeiro da Silva,Paulo Henrique Ribeiro Fernandes Almeida,Francisco de Assis Acurcio,Brian Godman,Amanj Kurdi,Amanj Kurdi,Mariângela Leal Cherchiglia,Eli Iola Gurgel Andrade +12 more
TL;DR: Bvacizumab represents a hope for increased survival and a chance of metastasectomy for patients with mCRC, however, there are serious adverse events associated with its use, especially severe hypertension and gastrointestinal perforation, that need to be considered.
Journal ArticleDOI
Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa: implications for the future
Brian Godman,Debashis Basu,Yogan Pillay,Paulo Henrique Ribeiro Fernandes Almeida,Julius Chacha Mwita,Godfrey Mutashambara Rwegerera,Bene D. Anand Paramadhas,Celda Tiroyakgosi,Okwen Patrick,Loveline Lum Niba,Israel Abebrese Sefah,Margaret Oluka,Anastasia N. Guantai,Dan Kibuule,Francis Kalemeera,Mwangana Mubita,Joseph O Fadare,Olayinka O Ogunleye,Enos M Rampamba,J. R. Wing,Debjani Mueller,Abubakr A. Alfadl,Adefolarin A Amu,Zinhle Matsebula,Aubrey Chichonyi Kalungia,Trust Zaranyika,Nyasha Masuka,Janney Wale,Ruaraidh Hill,Amanj Kurdi,Amanj Kurdi,Angela Timoney,Angela Timoney,Stephen Campbell,Stephen Campbell,Johanna C Meyer +35 more
TL;DR: There are concerns with the management of patients with T1DM across Africa, and there are ongoing developments to address the multiple challenges including the instigation of universal health care and partnerships with non-governmental organizations, patient organizations, and pharmaceutical companies.
Journal ArticleDOI
Stage at diagnosis and stage-specific survival of breast cancer in Latin America and the Caribbean: A systematic review and meta-analysis.
Lívia Lovato Pires de Lemos,Mirian Carvalho de Souza,Daniela Pena Moreira,Paulo Henrique Ribeiro Fernandes Almeida,Brian Godman,Brian Godman,Stéphane Verguet,Augusto Afonso Guerra Junior,Mariangela Leal Cherchiglia +8 more
TL;DR: LAC countries should look to address concerns with early detection and diagnosis of breast cancer, and wherever viable implement screening programs and to provide timely treatment, as expected the results varied widely from study to study.
Journal ArticleDOI
Pharmacist-led medication reconciliation at patient discharge: A scoping review.
Brígida Dias Fernandes,Paulo Henrique Ribeiro Fernandes Almeida,Aline Aparecida Foppa,Camila Tavares Sousa,Lorena Rocha Ayres,Clarice Chemello +5 more
TL;DR: The concept of MR and the pharmacist-led activities in the process varied in the literature, as well as the pharmacotherapy assessment focus and the communication strategies towards patients and other care providers, showing that standardization of the process and concepts is necessary.